Abstract

Orexo is product-focused drug delivery company that develops proprietary pharmaceuticals to address areas of unmet therapeutic need. The company’s development activities are commercially driven and is focused on tablet-based fast-dissolving or sublingual formulations for the treatment of acute conditions or symptoms such as breakthrough pain and sleeping disorders, where a fast and reproducible onset of action is desirable...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018